Delivery Order SPE2DR25D7059-SPE2DR26F7MXJ
Award Date 12/15/25
Potential Completion Date 12/16/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 26, 2025, for ENGERIX-B 20 MCG/ML syringes valued at $10,585.33. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025, issued under the Defense Logistics Agency's Medical Supply Chain. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,217.67 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on a firm fixed price basis, with delivery expected by December 9, 2025. This non-set-aside award represents a competitive procurement action and leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical supply needs. The contract was awarded to the vendor's corporate office located in Conshohocken,...
- The Defense Logistics Agency awarded a $30,338.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. The contract, which is scheduled for completion by August 7, 2025, represents a non-set-aside competitive award and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.56 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract was competitively awarded without set-aside designation on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is priced on a firm fixed-price basis and represents a routine...
- AmerisourceBergen Drug Corp was awarded a $1,179.62 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 8, 2025, for the supply of Engerix-B Pedi 10 mcg/0.5 mL vaccine syringes. The contract, which is a child order under a larger vehicle, carries an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine on June 3, 2025, with a ceiling value of $3,753.42. This is a firm fixed price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $11,355.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of December 16, 2025. This competitively awarded contract, issued without set-aside designation, leverages AmerisourceBergen's position as a critical pharmaceutical distributor within the federal medical supply chain. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.68 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for $4,542.98 to supply ENGERIX-B 20 MCG/ML syringes. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, executed without a set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters. This award represents a...